Intervention

Insulin Glargine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 94 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials94
Recruiting1
Common conditions23
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesNCT05553093 · 2022-03-15
RECRUITING
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaNCT06370715 · 2024-04-18
COMPLETED
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03
COMPLETED
To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic DrugsNCT05699408 · 2023-03-31
COMPLETED
To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.NCT05702073 · 2023-03-31
COMPLETED
Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource SettingsNCT05614089 · 2023-03-15
COMPLETED
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesNCT06127433 · 2023-03-07
UNKNOWN
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)NCT05662332 · 2023-01-14
COMPLETED
A Study of LY3209590 in Chinese Participants With Type 2 Diabetes MellitusNCT05596747 · 2022-11-30
COMPLETED
Early Administration of Insulin Glargine in Patients With Diabetic KetoacidosisNCT06007508 · 2022-05-31
TERMINATED
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 DiabetesNCT07282054 · 2022-04-13
COMPLETED
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase ActivityNCT05098470 · 2022-03-07
ACTIVE_NOT_RECRUITING
Intensive Glycemic Control For Diabetic Foot Ulcer HealingNCT04323462 · 2021-10-01
UNKNOWN
A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes MellitusNCT04957914 · 2021-07-14
COMPLETED
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsNCT05360537 · 2021-04-01
COMPLETED
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesNCT04591626 · 2020-12-07
COMPLETED
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)NCT04605991 · 2020-11-04
COMPLETED
Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine DoseNCT04623086 · 2020-02-14
COMPLETED
A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaNCT04153981 · 2019-12-16
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)NCT04093752 · 2019-12-09
COMPLETED
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesNCT03952130 · 2019-05-29
COMPLETED
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesNCT03952143 · 2019-05-27
COMPLETED
A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT03951805 · 2019-05-09
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07
COMPLETED
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskNCT03730662 · 2018-11-20
COMPLETED
Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.NCT03668808 · 2018-11-16
COMPLETED
Simplified Insulin Regimen for the ElderlyNCT03660553 · 2018-10-10
TERMINATED
Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in RamadanNCT03349840 · 2018-01-07
TERMINATED
A Study of LY3209590 in Participants With Type 2 DiabetesNCT03367377 · 2018-01-03
COMPLETED
Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of InsulinNCT03400501 · 2017-10-01
COMPLETED
A Study of LY900014 in Participants With Type 1 DiabetesNCT03214367 · 2017-07-17
COMPLETED
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesNCT03214380 · 2017-07-14
COMPLETED
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixiNCT03130426 · 2017-06-27
COMPLETED
A Study of LY3209590 in Healthy Participants and Participants With Type 2 DiabetesNCT02942914 · 2016-12-20
COMPLETED
Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 DiabetesNCT02526810 · 2015-07-01
UNKNOWN
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes MellitusNCT02106364 · 2015-02-01
WITHDRAWN
A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsNCT02197520 · 2014-07-01
COMPLETED
A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsNCT02152384 · 2014-06-01
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesNCT02152371 · 2014-05-01
COMPLETED
A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesNCT02132637 · 2014-05-01
COMPLETED
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)NCT02072096 · 2014-02-01
TERMINATED
A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 DiabeticsNCT01925989 · 2013-11-01
COMPLETED
Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes MellitusNCT02680457 · 2013-11-01
COMPLETED
A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesNCT01771250 · 2013-10-01
COMPLETED
A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentNCT01894568 · 2013-07-01
COMPLETED
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesNCT01849289 · 2013-06-02
COMPLETED
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 DiabetesNCT01784211 · 2013-02-01
COMPLETED
A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesNCT01769404 · 2013-02-01
COMPLETED
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosisNCT02006342 · 2012-11-01
COMPLETED
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)NCT01682759 · 2012-09-10
COMPLETED
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)NCT01524705 · 2012-08-01
COMPLETED
Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without MetforminNCT01596504 · 2012-05-01
COMPLETED
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)NCT01462266 · 2012-01-13
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01468987 · 2011-12-01
COMPLETED
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® UseNCT01500850 · 2011-10-01
UNKNOWN
Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesNCT01175824 · 2011-04-01
COMPLETED
Diabetes in the Elderly: Prospective StudyNCT01131052 · 2011-03-01
COMPLETED
A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusNCT01175811 · 2011-02-01
COMPLETED
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)NCT01191268 · 2010-11-01
COMPLETED
Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusNCT01226043 · 2010-10-01
COMPLETED

Trial status mix

COMPLETED80
TERMINATED7
UNKNOWN4
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1

Phase mix

PHASE341
PHASE436
PHASE110
NA3
PHASE23
EARLY_PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.